2024 Q3 Form 10-K Financial Statement

#000165495424012526 Filed on October 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $7.894K $5.234K
YoY Change 177.81%
Cost Of Revenue $53.19K $168.5K
YoY Change
Gross Profit -$45.30K -$163.3K
YoY Change -8768.05%
Gross Profit Margin -573.85% -3120.1%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $36.00K $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.722M $1.069M
YoY Change 8583.41% 520.86%
Operating Profit -$1.767M -$1.233M
YoY Change 8811.88% 623.58%
Interest Expense $1.357K $1.961K
YoY Change -51.95% -82.58%
% of Operating Profit
Other Income/Expense, Net -$1.355K $62.00
YoY Change -52.02% -98.36%
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.768M -$1.233M
YoY Change 7706.83% 639.91%
Net Earnings / Revenue -22401.85% -23551.17%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 10.60M shares 1.054B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.588K $38.97K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.621M $1.661M
Prepaid Expenses $0.00 $0.00
Receivables
Other Receivables
Total Short-Term Assets $13.48K $44.21K
YoY Change -88.83% -63.4%
LONG-TERM ASSETS
Property, Plant & Equipment $1.006K $1.208K
YoY Change -45.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.700M $1.751M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $13.48K $44.21K
Total Long-Term Assets $1.700M $1.751M
Total Assets $1.713M $1.795M
YoY Change 1319.81% 1386.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $107.9K $107.9K
YoY Change 17.35% 16.98%
Accrued Expenses $9.877K $9.877K
YoY Change 16.92% 74.54%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $239.8K $226.8K
YoY Change 13.39% 13.81%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $239.8K $226.8K
Total Long-Term Liabilities
Total Liabilities $339.8K $277.3K
YoY Change 60.67% 39.14%
SHAREHOLDERS EQUITY
Retained Earnings -$4.914M -$3.150M
YoY Change 39.6% -9.93%
Common Stock $10.60K $10.55K
YoY Change -50.22% -50.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.373M $1.476M
YoY Change
Total Liabilities & Shareholders Equity $1.713M $1.795M
YoY Change 1319.81% 1386.61%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$1.768M -$1.233M
YoY Change 7706.83% 639.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$229.6K -$2.431M
YoY Change 208670.91% 4620.07%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.289M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $196.3K $2.191M
YoY Change 31204.77%
NET CHANGE
Cash From Operating Activities -$229.6K -$2.431M
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $196.3K $2.191M
Net Change In Cash -$33.38K -$239.8K
YoY Change -725.15% 1928.47%
FREE CASH FLOW
Cash From Operating Activities -$229.6K -$2.431M
Capital Expenditures $0.00
Free Cash Flow -$2.431M
YoY Change 4408.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 usd
CY2023Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
50000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1475926 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
707629 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518038 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
707629 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001796949
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10205195 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10548191 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-56214
CY2024 dei Entity Registrant Name
EntityRegistrantName
GenFlat Holdings, Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3639946
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
1983 N Berra Blvd
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Tooele
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84074
CY2024 dei City Area Code
CityAreaCode
435
CY2024 dei Local Phone Number
LocalPhoneNumber
830-6979
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
31089426 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10604524 shares
CY2024 dei Auditor Firm
AuditorFirmId
2738
CY2024 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2024 dei Auditor Firm
AuditorFirmId
2738
CY2024 dei Auditor Location
AuditorLocation
The Woodlands, TX
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
441450 usd
CY2023 hbr Recapitalization Amount
RecapitalizationAmount
0 usd
CY2023 hbr Common Stock Sold For Cash Amount
CommonStockSoldForCashAmount
1142000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-875821 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
707629 usd
CY2024 hbr Common Stock Sold For Cash Amount
CommonStockSoldForCashAmount
2289300 usd
CY2024 hbr Recapitalization Amount
RecapitalizationAmount
-246223 usd
CY2024 hbr Issuance Of Common Stock For Reverse Stock Split Amount
IssuanceOfCommonStockForReverseStockSplitAmount
0 usd
CY2024 hbr Reclassification Of Noncontrolling Interest Amount
ReclassificationOfNoncontrollingInterestAmount
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-1232668 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518038 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
-116 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12679 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1740220 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2024 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1300 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2413 usd
CY2024 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
128466 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100000 usd
CY2024 hbr Increased Decreased In Convetible Note Amount
IncreasedDecreasedInConvetibleNoteAmount
150000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15800 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024 hbr Number Of Options Cancelled And Expired
NumberOfOptionsCancelledAndExpired
-7700 shares
CY2024 hbr Weighted Average Exercise Price Cancelled And Expired
WeightedAverageExercisePriceCancelledAndExpired
50.00
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
8100 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
64.00
CY2024Q2 hbr Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice Ending Balance
SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercisepriceEndingBalance
0
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 hbr Change In Valuation Allowance
ChangeInValuationAllowance
0.21 pure
CY2023 hbr Change In Valuation Allowance
ChangeInValuationAllowance
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
255020 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
183922 usd
CY2024 hbr Income Tax Expense Valuation Allowance
IncomeTaxExpenseValuationAllowance
-255020 usd
CY2023 hbr Income Tax Expense Valuation Allowance
IncomeTaxExpenseValuationAllowance
-183922 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3100000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
661574 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
406554 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
661574 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
406554 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
5000 usd

Files In Submission

Name View Source Status
0001654954-24-012526-index-headers.html Edgar Link pending
0001654954-24-012526-index.html Edgar Link pending
0001654954-24-012526.txt Edgar Link pending
0001654954-24-012526-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hbr-20240630.xsd Edgar Link pending
hbr_10k.htm Edgar Link pending
hbr_10kimg1.jpg Edgar Link pending
hbr_ex101.htm Edgar Link pending
hbr_ex1010.htm Edgar Link pending
hbr_ex109.htm Edgar Link pending
hbr_ex141.htm Edgar Link pending
hbr_ex211.htm Edgar Link pending
hbr_ex311.htm Edgar Link pending
hbr_ex312.htm Edgar Link pending
hbr_ex321.htm Edgar Link pending
hbr_ex322.htm Edgar Link pending
hbr_ex41.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hbr-20240630_cal.xml Edgar Link unprocessable
hbr-20240630_def.xml Edgar Link unprocessable
hbr-20240630_lab.xml Edgar Link unprocessable
hbr-20240630_pre.xml Edgar Link unprocessable
hbr_10k_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending